Welcome to Chinese Journal of Clinical Pharmacology and Therapeutics,Today is Share:

Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2020, Vol. 25 ›› Issue (9): 968-975.doi: 10.12092/j.issn.1009-2501.2020.09.002

Previous Articles     Next Articles

Resveratrol regulates miR-409-3p/FKBP14 to inhibit the malignant biological processes of gastric cancer BGC823 cells

WU Yi, ZHU Akao, SHAN Yuqiang, YING Rongchao, JIN Huicheng   

  1. Hangzhou First People's Hospital, Gastrointestinal and Anal Surgery, Hangzhou 310006, Zhejiang, China
  • Received:2020-05-06 Revised:2020-06-01 Online:2020-09-26 Published:2020-09-30

Abstract: AIM: To investigate the effect of resveratrol (RES) on the malignant biological processes of gastric cancer (GC) cells. METHODS: CCK-8 assay was used to study the effect of RES on the viability of BGC823 cells; qRT-PCR was used to detect the regulation of RES on the expression of miR-409-3p; EdU assay was used to study the effect of RES on the proliferation of BGC823 cells; transwell assay was used to study the effect of RES on the migration and invasion of BGC823 cells; luciferase reporter assay and western blot assay were used to study the regulation of miR-409-3p on the expression of FKBP14. RESULTS: RES (>200 μmol/L) significantly inhibited the viability of BGC823 cells. RES inhibited the proliferation, migration and invasion of gastric cancer cells by up-regulating miR-409-3p. FKBP14 was the target gene of miR-409-3p. Res could inhibit the expression of FKBP14 in gastric cancer cells by up-regulating miR-409-3p. Overexpression of FKBP14 attenuated the antitumor effect of RES. CONCLUSION: RES can suppress the tumor progression in gastric cancer by regulating miR-409-3p/FKBP14 signaling pathway, indicating the potential value of RES in clinical treatment of gastric cancer.

Key words: resveratrol, gastric cancer, miR-409-3p

CLC Number: